BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise - Nov. 22, 2017

  The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others.

  November 22, 2017

   · 

  3 min read
• Business

  AroCell Signs Letter of Intent With Korean-Based Company, Green Cross Cell Corporation

  he companies have agreed to enter into a collaboration for the clinical development of TK 210 ELISA.

  November 22, 2017

   · 

  2 min read
• Prima Secures European Patent Grant for Lead Product IMP321 in Cancer

  This European patent was filed as a divisional application and follows the grant of the European parent patent, which was issued in August 2013.

  November 22, 2017

   · 

  1 min read
• Alzheimer’s Research UK Release: Autumn Budget Misses Mark for Dementia

  Alzheimer’s Research UK is calling on the government to make continued commitments that support world-class research to address dementia.

  November 22, 2017

   · 

  1 min read
• Deals

  Orig3n Acquires Interleukin Genetics, a Genetics-Based Personalized Health Company, to Advance the Future of Health Faster

  The automated genotyping lab is fully-licensed for testing in all 50 U.S. states and is capable of processing over one million samples per year.

  November 22, 2017

   · 

  3 min read
• Policy

  ArisGlobal is First Life Pharmacovigilance Solutions Provider to Successfully Complete Testing With EMA E2B(R3) Import Export Functionality

  Meeting the November 22, 2017 deadline set by EMA will give ArisGlobal’s 200+ customers the peace of mind that they will be fully compliant with EMA’s landmark regulatory requirement.

  November 22, 2017

   · 

  3 min read
• Business

  Nektar Announces Key Executive Promotions to Drive the Continued Growth of the Company’s Immuno-Oncology Pipeline

  Nektar Therapeutics announced today several promotions on its executive leadership team.

  November 22, 2017

   · 

  5 min read
• Business

  Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results

  Quarterly sales from continuing operations were $31.4M compared to $23M in the prior year period, an increase of 36.7%.

  November 22, 2017

   · 

  56 min read
• Tetra Bio-Pharma’s Business Model and Commercialization Strategy in Line With the Canadian Government’s Proposed Approach to the Regulation of Cannabis

  The proposed approach to regulation recommends that cannabis-based health products are still subject to scientific review and must show significant efficacy, meet strict safety requirements and be of sufficient quality in order to gain market approval as a drug or as a natural health product.

  November 22, 2017

   · 

  5 min read
• 

  Business

  Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX (neratinib) in Australia, New Zealand and South East Asia

  Puma will receive upfront and milestone payments of up to $4.5 million throughout the term of this agreement.

  November 22, 2017

   · 

  9 min read